Cooper Companies Target of Unusually Large Options Trading (NASDAQ:COO)

The Cooper Companies, Inc. (NASDAQ:COO) saw unusually large options trading activity on Monday. Investors purchased 4,486 call options on the stock. This represents an increase of 534% compared to the average daily volume of 708 call options.

Analyst Upgrades and Downgrades

COO has been the subject of several research analyst reports. Mizuho set a $85.00 price target on Cooper Companies and gave the stock an “outperform” rating in a research note on Thursday, June 4th. Needham & Company LLC dropped their target price on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Stifel Nicolaus cut their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday, June 1st. Finally, Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $81.36.

Cooper Companies Stock Up 2.1%

Shares of COO stock traded up $1.59 during mid-day trading on Monday, hitting $75.82. The company’s stock had a trading volume of 441,489 shares, compared to its average volume of 2,385,922. The stock has a market cap of $14.79 billion, a price-to-earnings ratio of 64.14, a PEG ratio of 1.94 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. Cooper Companies has a 52-week low of $58.89 and a 52-week high of $89.83. The business has a 50-day moving average price of $69.64 and a 200 day moving average price of $71.44.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period last year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts predict that Cooper Companies will post 4.63 EPS for the current fiscal year.

Institutional Investors Weigh In On Cooper Companies

Institutional investors and hedge funds have recently bought and sold shares of the business. Avalon Trust Co purchased a new position in Cooper Companies during the second quarter valued at approximately $25,000. Root Financial Partners LLC increased its holdings in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the period. SJS Investment Consulting Inc. raised its position in shares of Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares in the last quarter. Elevation Wealth Partners LLC lifted its stake in shares of Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after purchasing an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp bought a new stake in Cooper Companies during the second quarter valued at about $32,000. 24.39% of the stock is owned by institutional investors.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.